Tarik Skubal trade: six other MLB superstars who could be traded soon

Show summary Hide summary

• How Skubal’s nanoscope procedure could reshuffle the trade market
• Yordan Álvarez: Power bat that would help any contender
  • Why teams value him
• Freddy Peralta: Starting rotation help with controllable upside
  • What Peralta brings to the table
• Jarren Duran: A buy-low candidate with past upside
  • Struggles and potential
• Sandy Alcántara: Veteran innings and Cy Young pedigree
  • Why he matters in trade talks
• Joe Ryan: Controlled asset with trade appeal
  • Pros and potential red flags
• C.J. Abrams: Young shortstop with breakout upside and trade value
  • Why Abrams could be a centerpiece

Tarik Skubal’s latest elbow operation is already being talked about as a turning point for pitcher recovery—and for the July trade market. Two weeks after undergoing a minimally invasive procedure with a nanoscope, the Detroit Tigers lefty is back to throwing full-speed bullpen sessions, a recovery timeline that would have sounded optimistic only months ago.

Surgeon Dr. Neal ElAttrache used a new instrument that teammates and reporters have nicknamed the “Skubal Scope”, and the early results are changing how teams evaluate the risk of acquiring high-end arms before the Aug. 3 trade deadline. With Skubal eligible for a massive free-agent payday this winter, his accelerated return could reshape contender strategies.

How Skubal’s nanoscope procedure could reshuffle the trade market

Skubal’s rehab has become as much a storyline as his rising fastball. The quick recovery is forcing front offices to weigh whether acquiring an injured ace is worth the short-term wait, since the nanoscope approach appears to shrink typical downtime.

• Fast return: throwing at full velocity within two weeks of surgery suggests shorter rehabilitation windows for elbow procedures.
• Trade impact: contenders that once hesitated to trade for pitchers with recent elbow work may now be more aggressive before the Aug. 3 deadline.
• Payroll implications: Skubal projects as a top-tier free agent this winter—figures in the hundreds of millions have been mentioned—so postseason hopefuls could bet on short-term acquisition versus long-term contract costs.

The Tigers, sitting near the bottom of the AL Central, must decide whether to hold onto their budding ace if the team remains out of contention. If Detroit moves Skubal, the ripple effects extend through the market: other teams may be willing to trade premium prospects for pitchers who once would have been considered too risky.

Yordan Álvarez: Power bat that would help any contender

Why teams value him

Yordan Álvarez has been one of the most dangerous hitters in baseball this season, producing elite on-base and slugging numbers while splitting time between left field and designated hitter. He’s a natural middle-of-the-order option for clubs looking for instant offensive impact.

• Current line: roughly .316/.423/.638 with 15 home runs at the time of reporting.
• Contract: earning about $26.8 million this season with two more seasons at the same salary before reaching free agency.
• Fit: fits as a left fielder or DH, ideal for teams craving middle-of-the-lineup power.

Freddy Peralta: Starting rotation help with controllable upside

What Peralta brings to the table

Peralta has given clubs strong starting innings and has been mentioned in trade conversations as teams chase rotation depth. Through his first 10 starts he’s shown an ERA around the low 3.00s with a healthy strikeout total—numbers that make him an attractive midseason target.

• Performance snapshot: roughly a 3.31 ERA with about 54 strikeouts in his early-season starts.
• Contract status: set to reach free agency this November, which could motivate his current team to consider moving him if they’re out of the race.
• Why contenders bite: provides immediate, controllable rotation innings down the stretch and into a playoff push.

Jarren Duran: A buy-low candidate with past upside

Struggles and potential

Jarren Duran’s start to the year has been rough, producing one of the lowest offensive lines through his first 40-plus games. Still, his track record includes an All-Star nod and above-average production in recent seasons, making him a classic buy-low option for teams that can trigger a rebound.

• Early-season numbers: around .183/.243/.305 in his first 41 games.
• Track record: was notably better from 2023–2025, roughly 25% above league average offensively.
• Control: under team control until 2029; turns 30 in September.

Boston could consider moving Duran if outfield prospects return from injury and the club prefers to shift roster slots. A contender in need of a low-cost outfielder with upside might gamble on a midseason turnaround.

Sandy Alcántara: Veteran innings and Cy Young pedigree

Why he matters in trade talks

Sandy Alcántara remains a high-leverage name because of his track record: multiple All-Star selections and a Cy Young award. Even two years after Tommy John surgery, he’s offered reliable innings, though his strikeout numbers this season haven’t exploded.

• Accolades: two-time All-Star and 2022 NL Cy Young winner.
• Role: provides steady frontline starts for teams needing long outings.
• Contract situation: making about $17.3 million now, with a team option of roughly $21 million (and a $2 million buyout) for 2027.

Joe Ryan: Controlled asset with trade appeal

Pros and potential red flags

Joe Ryan has consistently ranked among the better pitchers by advanced metrics since 2022, and he’s the kind of controllable starter that contenders often target at the deadline. He’s an All-Star-caliber arm who could be packaged for a significant return if his club decides to sell.

• Recent form: All-Star last season and top-15 in WAR-level performance since 2022.
• Contract nuances: mutual option for around $13 million next season with a small buyout (about $100,000).
• Risk: second-half performance has historically dipped (career second-half ERA near the mid-4.00s over a sample), a factor suitors will weigh.

C.J. Abrams: Young shortstop with breakout upside and trade value

Why Abrams could be a centerpiece

C.J. Abrams is crossing the threshold offensively—already above league average and flashing multi-tool potential. If he fulfills his projection, he could deliver both power and speed, making him an attractive core piece for a contender or a valuable trade chip if his team decides to retool.

• Age and profile: 25 years old, developing into a potential 30-30 threat.
• Defense: still below average at shortstop, which could influence long-term plans at the position.
• Team context: club has prospects like Eli Willits in the pipeline, potentially influencing whether Abrams remains at short or is moved.
• Control: team control into 2029, giving his club flexibility.

Front offices will balance Abrams’ immediate production and long-term fit—he’s the sort of young star who could anchor a lineup or fetch a substantial return in a trade if the parent club opts to reshape its roster.

You might also like:

• Tarik Skubal, Detroit Tigers $250 million contract standoff explained
• Tarik Skubal’s quick recovery boosts Detroit Tigers’ hopes in AL Central race
• Brewers target Tarik Skubal in blockbuster MLB trade
• MLB trades that could shake up the league: three realistic deals
• NFL trade deadline 2025: top 3 players who could change teams